CPB Stock Analysis: Campbell’s | NASDAQ

Packaged Foods | NASDAQ, USA | Market Cap: 5.851m USD | 12M Return: -31.6% | US1344291091 | Charts, Fundamentals & Technical Analysis

Soups, Sauces, Snacks, Beverages
Total Rating 25
Safety 60
Buy Signal -1.41
Packaged Foods
Industry Rotation: +3.0
Market Cap: 5.85B
Avg Turnover: 148M
Risk 3d forecast
Volatility26.9%
VaR 5th Pctl4.81%
VaR vs Median8.52%
Reward TTM
Sharpe Ratio-1.17
Rel. Str. IBD14.5
Rel. Str. Peer Group33.7
Character TTM
Beta-0.164
Beta Downside0.163
Hurst Exponent0.469
Drawdowns 3y
Max DD59.19%
CAGR/Max DD-0.30
CAGR/Mean DD-0.69
EPS (Earnings per Share) EPS (Earnings per Share) of CPB over the last years for every Quarter: "2021-10": 0.89, "2022-01": 0.69, "2022-04": 0.7, "2022-07": 0.56, "2022-10": 1.02, "2023-01": 0.8, "2023-04": 0.68, "2023-07": 0.5, "2023-10": 0.91, "2024-01": 0.8, "2024-04": 0.75, "2024-07": 0.63, "2024-10": 0.89, "2025-01": 0.74, "2025-04": 0.73, "2025-07": 0.62, "2025-10": 0.77, "2026-01": 0.51, "2026-04": 0.5, "2026-07": 0.39,
EPS CAGR: -8.22%
EPS Trend: -71.3%
Last SUE: -0.26
Qual. Beats: 0
Revenue Revenue of CPB over the last years for every Quarter: 2021-10: 2236, 2022-01: 2209, 2022-04: 2130, 2022-07: 1987, 2022-10: 2575, 2023-01: 2485, 2023-04: 2229, 2023-07: 2068, 2023-10: 2518, 2024-01: 2456, 2024-04: 2369, 2024-07: 2293, 2024-10: 2772, 2025-01: 2685, 2025-04: 2475, 2025-07: 2321, 2025-10: 2677, 2026-01: 2564, 2026-04: 2366, 2026-07: 2137,
Rev. CAGR: 2.78%
Rev. Trend: 67.7%
Last SUE: -0.23
Qual. Beats: 0

Warnings

Below Avwap Earnings
Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 11.7 years of data

Jan +1.8% 8
Feb -1.4% 19
Mar +0.2% 17
Apr -1.5% 8
May -2.3% 20
Jun -0.3% 7
Jul +1.3% 23
Aug +0.4% 10
Sep -3.0% 16
Oct -0.3% 25
Nov +3.1% 29
Dec -0.6% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: CPB Campbell’s

The Campbells Company (NASDAQ: CPB) is a U.S.-based packaged food manufacturer that operates through two reporting segments: Meals & Beverages (sold primarily in the U.S. and Canada) and Snacks (sold globally, including in Latin America). The Meals & Beverages segment covers soups, broths, pasta sauces, Mexican sauces, juices, frozen entrées, and yogurts under brands such as Campbells, Swanson, Pacific Foods, Prego, Pace, V8, Raos, Michael Angelos, and Noosa. The Snacks segment covers cookies, crackers, pretzels, and chips under brands including Pepperidge Farm, Goldfish, Snyders of Hanover, Lance, Cape Cod, Kettle Brand, Late July, and Snack Factory.

Products are sold across a broad channel mix that includes retail food chains, mass discounters, mass merchandisers, club stores, convenience stores, dollar stores, e-commerce, foodservice, and independent contractor distributors. The company was founded in 1869, is headquartered in Camden, New Jersey, and was renamed from Campbell Soup Company to The Campbells Company in November 2024.

CPB sits within the Packaged Foods & Meats sub-industry of Consumer Staples, a defensive category characterized by steady demand and pricing power tied to brand equity rather than volume growth. The dual-segment structure pairs shelf-stable meals (typically center-store grocery) with shelf-stable snacks (often distributed via direct-store-delivery networks), giving the company exposure to both grocery and convenience/snacking occasions.

Headlines to Watch Out For
  • Sovos Brands integration drives premium Raos pasta sauce growth
  • Snacks segment margins expand on Snyders and Goldfish pricing power
  • Soup category volume decline pressures Meals & Beverages revenue
Piotroski VR-10 (Strict) 1.0
Net Income: 403.0m TTM > 0 and > 6% of Revenue
FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.40 > 1.0
NWC/Revenue: -6.32% < 20% (prev -6.57%; Δ 0.25% < -1%)
CFO/TA 0.07 > 3% & CFO 1.04b > Net Income 403.0m
Net Debt (7.17b) to EBITDA (1.26b): 5.67 < 3
Current Ratio: 0.82 > 1.5 & < 3
Outstanding Shares: last quarter (300.0m) vs 12m ago 0.33% < -2%
Gross Margin: 28.14% > 18% (prev 30.42%; Δ -2.28% > 0.5%)
Asset Turnover: 63.80% > 50% (prev 68.83%; Δ -5.03% > 0%)
Interest Coverage Ratio: 2.64 > 6 (EBIT TTM 852.0m / Interest Expense TTM 323.0m)
Altman Z'' 1.43
A: -0.04 (Total Current Assets 2.72b - Total Current Liabilities 3.34b) / Total Assets 15.6b
B: 0.30 (Retained Earnings 4.62b / Total Assets 15.6b)
C: 0.06 (EBIT TTM 852.0m / Avg Total Assets 15.3b)
D: 0.34 (Book Value of Equity 3.85b / Total Liabilities 11.5b)
Altman-Z'' = 1.43 = BB
Beneish M -2.96
DSRI: 1.04 (Receivables 578.0m/583.0m, Revenue 9.74b/10.3b)
GMI: 1.08 (GM 30.42% / 28.14%)
AQI: 1.00 (AQ_t 0.64 / AQ_t-1 0.64)
SGI: 0.95 (Revenue 9.74b / 10.3b)
TATA: -0.04 (NI 403.0m - CFO 1.04b) / TA 15.6b)
Beneish M = -2.96 (Cap -4..+1) = A
What is the price of CPB shares?

As of October 12, 2026, the stock is trading at USD 19.21 with a total of 7,043,784 shares traded. Over the past week, the price has changed by -2.09%, over one month by -11.08%, over three months by -9.38% and over the past year by -31.62%.

Current recommended Stop Loss: 18.20 (which is 5.3% or 1.6 ATR below the current price).

Is CPB a buy, sell or hold?

Campbell’s has received a consensus analysts rating of 2.70. Therefore, it is recommended to hold CPB.

  • StrongBuy: 1
  • Buy: 0
  • Hold: 13
  • Sell: 4
  • StrongSell: 2

What are the forecasts/targets for the CPB price?
Analysts Target Price 20.8 8.2%
Campbell’s (CPB) - Fundamental Data Overview as of 05 October 2026
Market Cap USD = 5.85b (5.85b USD * 1.0 USD.USD)
P/E Trailing = 14.9771
P/E Forward = 11.8765
P/S = 0.6005
P/B = 1.577
P/EG = 0.5253
Revenue TTM = 9.74b USD
EBIT TTM = 852.0m USD
EBITDA TTM = 1.26b USD
Long Term Debt = 6.15b USD (from longTermDebt, two quarters ago)
Short Term Debt = 977.0m USD (from shortTermDebt, last quarter)
Debt = 7.56b USD (from shortLongTermDebtTotal, last quarter) + Leases 425.0m
Net Debt = 7.17b USD (calculated: Debt 7.56b - CCE 394.0m)
Enterprise Value = 13.0b USD (5.85b + Debt 7.56b - CCE 394.0m)
Interest Coverage Ratio = 2.64 (Ebit TTM 852.0m / Interest Expense TTM 323.0m)
EV/FCF = 19.20x (Enterprise Value 13.0b / FCF TTM 678.0m)
FCF Yield = 5.21% (FCF TTM 678.0m / Enterprise Value 13.0b)
FCF Margin = 6.96% (FCF TTM 678.0m / Revenue TTM 9.74b)
Net Margin = 4.14% (Net Income TTM 403.0m / Revenue TTM 9.74b)
Gross Margin = 28.14% ((Revenue TTM 9.74b - Cost of Revenue TTM 7.00b) / Revenue TTM)
Gross Margin QoQ = 27.28% (prev 27.47%)
Tobins Q-Ratio = 0.83 (Enterprise Value 13.0b / Total Assets 15.6b)
Interest Expense / Debt = 4.27% (Interest Expense 323.0m / Debt 7.56b)
Taxrate = 23.44% (124.0m / 529.0m)
NOPAT = 652.3m (EBIT 852.0m * (1 - 23.44%))
Current Ratio = 0.82 (Total Current Assets 2.72b / Total Current Liabilities 3.34b)
Debt / Equity = 1.96 (Debt 7.56b / totalStockholderEquity, last quarter 3.85b)
Debt / EBITDA = 5.67 (Net Debt 7.17b / EBITDA 1.26b)
Debt / FCF = 10.57 (Net Debt 7.17b / FCF TTM 678.0m)
Total Stockholder Equity = 3.96b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.64% (Net Income 403.0m / Total Assets 15.6b)
RoE = 10.18% (Net Income TTM 403.0m / Total Stockholder Equity 3.96b)
RoCE = 8.43% (EBIT 852.0m / Capital Employed (Equity 3.96b + L.T.Debt 6.15b))
RoIC = 5.06% (NOPAT 652.3m / Invested Capital 12.9b)
WACC = 4.20% (E(5.85b)/V(13.4b) * Re(5.41%) + D(7.56b)/V(13.4b) * Rd(4.27%) * (1-Tc(0.23)))
Discount Rate = 5.41% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -6.69 | Cagr: 0.0%
[DCF] Terminal Value 74.91% ; FCFF base≈688.8m ; Y1≈669.5m ; Y5≈664.5m
[DCF] Fair Price = 10.87 (EV 10.4b - Net Debt 7.17b = Equity 3.24b / Shares 298.2m; r=8.35% [WACC [floored]]; 5y FCF grow -3.83% → 2.50% )
EPS Correlation: -71.27 | EPS CAGR: -8.22% | SUE: -0.26 | # QB: 0
Revenue Correlation: 67.71 | Revenue CAGR: 2.78% | SUE: -0.23 | # QB: 0
EPS current Quarter (2026-10-31): EPS=0.41 | Chg30d=-30.98% | Revisions=-67% | Analysts=16
EPS next Quarter (2027-01-31): EPS=0.42 | Chg30d=-8.23% | Revisions=-67% | Analysts=16
EPS current Year (2027-07-31): EPS=1.70 | Chg30d=-10.18% | Revisions=-85% | GrowthEPS=-21.8% | GrowthRev=-2.5%
EPS next Year (2028-07-31): EPS=1.84 | Chg30d=-10.91% | Revisions=-75% | GrowthEPS=+8.2% | GrowthRev=-0.3%
[Analyst] Revisions Ratio: -87% (up=2, down=48)